UNITEDHEALTH GROUP INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $447.6B | $400.3B | $371.6B | $324.2B | $287.6B |
| Selling, general & administrative | $59.6B | $53.0B | $54.6B | $47.8B | $42.6B |
| Operating income | $19.0B | $32.3B | $32.4B | $28.4B | $24.0B |
| Interest expense | $4.0B | $3.9B | $3.2B | $2.1B | $1.7B |
| Pretax income | $14.7B | $20.1B | $29.1B | $26.3B | $22.3B |
| Income tax expense | $1.9B | $4.8B | $6.0B | $5.7B | $4.6B |
| Net income | $12.1B | $14.4B | $22.4B | $20.1B | $17.3B |
| Balance Sheet | |||||
| Cash and equivalents | $24.4B | $25.3B | $25.4B | $23.4B | $21.4B |
| Current assets | $90.6B | $85.8B | $78.4B | $69.1B | $61.8B |
| Total assets | $309.6B | $298.3B | $273.7B | $245.7B | $212.2B |
| Current liabilities | $114.9B | $103.8B | $99.1B | $89.2B | $78.3B |
| Total liabilities | $207.9B | $195.7B | $174.8B | $159.4B | $135.7B |
| Total debt | $77.7B | $76.2B | $61.5B | $56.8B | $44.6B |
| Stockholders' equity | $100.1B | $98.3B | $94.4B | $81.5B | $75.0B |
| Cash Flow Statement | |||||
| Cash from operations | $19.7B | $24.2B | $29.1B | $26.2B | $22.3B |
| Depreciation and amortization | $1.0B | $1.0B | $1.1B | $1.1B | $1.0B |
| Stock-based compensation | $971.0M | $1.0B | $1.1B | $925.0M | $800.0M |
| Capital expenditure | $3.6B | $3.5B | $3.4B | $2.8B | $2.5B |
| Free cash flow | $16.1B | $20.7B | $25.7B | $23.4B | $19.9B |
| Dividends paid | $7.9B | $7.5B | $6.8B | $6.0B | $5.3B |
| Share repurchases | $5.5B | $9.0B | $8.0B | $7.0B | $5.0B |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 908.1M · Free float 93.4%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.
Recent filings
- July 16, 2026 8-K
- June 5, 2026 8-K
- May 11, 2026 8-K
- May 5, 2026 10-Q
- April 21, 2026 8-K
- March 9, 2026 8-K
- March 2, 2026 8-K
- March 2, 2026 10-K